CXCL1 and neoplasm: Furthermore, our findings indicate CXCL1 chemokine as a strong candidate as a tissue differentiating biomarker and tumor histological stage indicator from patients’ serum, and IL1b overexpression as a molecular factor related to increased TNM stage.